This multifactorial approach resulted in the manifestation of typical clinical HFpEF features, including ventricular hypertrophy, increased collagen deposition and fibrosis, elevated blood pressure, and diastolic dysfunction
Quick Answer: GLP-1 receptor agonists produce significant reductions in abdominal fat and waist circumference as part of generalized weight loss, though they do not selectively target belly fat
Glucagon-like peptide-1 (GLP-1) is an incretin hormone primarily produced by intestinal L-cells in response to nutrient intake
However, the mechanism behind Ozempic face has not been fully understood
Metabolites 12:750 Assefa B, Tadesse A, Abay Z, Abebe A, Tesfaye T, Tadesse M, Molla A (2022) Peptic ulcer disease among dyspeptic patients at endoscopy unit, University of Gondar hospital, Northwest Ethiopia
These work much better as their dosage schedule has been created specifically with weight loss in mind